Try our Advanced Search for more refined results
Health
-
February 23, 2026
FedEx, Bausch, Other Cos. Join Race For Tariff Refunds
FedEx, Bausch & Lomb and L'Oreal are among the companies that raced to the U.S. Court of International Trade on Monday seeking full refunds of the trade duties they paid as a result of the 2025 tariffs that President Donald Trump illegally imposed under the International Emergency Economic Powers Act.
-
February 23, 2026
DC Circ. Talks Sharks, Moats In Vertex HHS Kickback Appeal
Sharks and moats were top of mind Monday morning for one judge on the D.C. Circuit, as gene therapy drugmaker Vertex Pharmaceuticals attempted to convince the court that its fertility preservation program does not violate the Anti-Kickback Statute.
-
February 23, 2026
Zynex Faces Securities Suit Following Arrest Of Former Execs
After being arrested last month on charges of securities fraud and conspiracy, the former CEO and ex-chief compliance officer of bankrupt medical device maker Zynex have been hit with a securities class action that alleges they and others caused the company to engage in fraudulent billing practices that inflated its stock price and led to investor losses once the truth came to light.
-
February 23, 2026
Fla. Hospital Blames UnitedHealth In Cyberattack Suit
A Florida hospital sued UnitedHealth Group Inc. and several subsidiaries in Georgia federal court on Friday, saying they didn't live up to their contractual obligations when a 2024 cyberattack left the hospital unable to process payments for weeks.
-
February 23, 2026
Philly-Area Fertility Clinic Settles Patient's Acid Burn Suit
A woman who sued a fertility clinic for allegedly mistakenly injecting her uterine cavity with acid, which she said caused her to suffer second-degree burns, has settled her lawsuit against the clinic for an undisclosed amount.
-
February 23, 2026
Disability Group Says Mich. Agency Isn't Honoring Judgment
A disability advocacy group asked a Michigan federal judge on Monday to order a county mental health agency to explain why it should not be held in civil contempt, saying the agency refused to follow new Medicaid budgeting rules that were adopted as part of a court-approved settlement.
-
February 23, 2026
SEC Says PPE Distributor Fabricated Pandemic-Era Deal
The U.S. Securities and Exchange Commission filed a suit Monday accusing the CEO and consultant of a consumer goods company of artificially inflating the company's share price by nearly 200% by disseminating a false press release touting $10 million in orders for health supplies at the beginning of the COVID-19 pandemic.
-
February 23, 2026
Asthma Biotech Generate Biomedicines Eyes $400M IPO
Asthma-focused biotech firm Generate Biomedicines on Monday filed plans with U.S. regulators to raise around $400 million in its initial public offering led by Goodwin Procter LLP and Latham & Watkins LLP.
-
February 23, 2026
Analyst Who Claimed She Was Fired For Needing Sleep Settles
A New Jersey woman who claimed she was fired by Centerview Partners after disclosing she needed consistent sleep to manage a health disorder settled her case against the investment bank ahead of a jury trial in New York federal court, the bank said Monday.
-
February 23, 2026
Pittsburgh Law Firm Hit With Class Claims Over Data Breach
A Pittsburgh-based law firm has been hit with proposed class claims alleging it failed to protect clients' private information, which was compromised by a data breach in May.
-
February 23, 2026
NJ Watchdog Takes File Fight In Hospital Row To 3rd Circ.
A New Jersey watchdog will take its bid to shield investigative files from discovery in a hospital's antitrust suit to the Third Circuit, according to a court notice.
-
February 23, 2026
Hims & Hers Misleads With GLP-1 Claims In Ads, Court Told
A class of GLP-1 patients claim that telehealth company Hims & Hers falsely advertised its compounded injections as made with "the same active ingredient" as weight loss drugs Ozempic and Wegovy despite containing other key ingredients, according to a suit filed in Illinois federal court.
-
February 23, 2026
Ropes, Wilson Sonsini Guide Gilead's $7.8B Arcellx Buy
Gilead Sciences Inc. announced Monday that it has agreed to acquire clinical-stage biotechnology company Arcellx Inc. for $115 per share in cash plus one contingent value right worth $5 per share, reflecting an implied equity value of $7.8 billion.
-
February 23, 2026
Kirkland, Jones Day Build $1.1B Hospice Take-Private Deal
Home health and hospice provider Enhabit Inc., advised by Jones Day, on Monday unveiled plans to go private following a sale to middle market private equity firm Kinderhook Industries LLC, led by Kirkland & Ellis LLP, in an all-cash deal valued at roughly $1.1 billion.
-
February 23, 2026
High Court Won't Wade Into Doctor's Retaliation Suit
The U.S. Supreme Court declined Monday to consider reviving a doctor's retaliation suit claiming a New York City-area hospital system forced his exit for raising patient safety concerns, despite his argument that the healthcare provider had withheld an email that supported his case.
-
February 20, 2026
Class Attys Allege Lead Counsel Is Hoarding $75M Sutter Fees
Schneider Wallace Cottrell Kim LLP has urged a California federal magistrate judge to enforce the $75.4 million fee award in Sutter Health's $228.5 million deal resolving a decade-long antitrust fight, arguing lead counsel Constantine Cannon LLP "unilaterally" and "arbitrarily" cut SWCK's fees by nearly $800,000 while boosting its own.
-
February 20, 2026
Texas AG Sues Retailer Over Chest Binder Sales To Youth
The Texas attorney general on Friday hit an online retailer with a suit alleging that it sells chest binders as undergarments to young people, in what appears to be the first suit in the state targeted at a product used in gender-affirming care.
-
February 20, 2026
Dallas Jury Finds Ex-NFL Player Ran $328M Medicare Scheme
A federal jury in Dallas has found that former NFL player and Texas laboratory owner Keith Gray orchestrated a $328 million fraud scheme involving billing for cardiovascular genetic testing, federal prosecutors said Thursday.
-
February 20, 2026
Fertility Doctors Beat Patient's Embryo Loss Case
A Connecticut woman waited too long to sue her fertility doctors over the loss of her frozen embryos after treatments in 2005 and 2006, a state court judge ruled Thursday, granting judgment to the doctors.
-
February 20, 2026
Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP
The Federal Circuit on Friday saved Regenxbio and the University of Pennsylvania's gene therapy patent, finding that splicing together genes from different organisms results in a molecule that is "markedly different from anything occurring in nature," rendering the therapy patent eligible.
-
February 20, 2026
DOJ Says Ohio Health System's Contracts Violate Antitrust
The U.S. Department of Justice and Ohio's attorney general's office sued OhioHealth Corp. Friday in federal court, accusing the healthcare system of using contractual restrictions to block insurers from offering plans that include lower-cost rivals.
-
February 20, 2026
Court OKs $376K Arb. Victory For Accountant In PWFA Suit
A Texas federal court approved a $376,000 arbitration award for a former community center accounting employee who alleged she was belittled by a supervisor and denied telework as a temporary accommodation following childbirth.
-
February 20, 2026
Kaiser Sues Insurers To Tap $95M D&O Policy For Fraud Deal
Kaiser Foundation Health Plan sued Chubb and other insurers in California federal court Friday seeking to tap $95 million in directors and officers liability coverage for a recently settled whistleblower action that accused Kaiser of submitting false diagnoses for Medicare Advantage Plan enrollees.
-
February 20, 2026
Biohazard Cleaning Co. Faces Unpaid Overtime Class Action
A Colorado professional biohazard remediation and technical cleaning services business violated federal and state law by failing to pay employees for overtime worked, according to a proposed class and collective action brought by the company's former employees in Colorado federal court.
-
February 20, 2026
Judge Says Texas Can't Enforce Optometry Anti-Steering Law
A Texas federal judge on Friday blocked the state from enforcing an anti-steering law that banned managed care plans from telling insureds about optometrists who offer cheaper options, saying that the law violated protected commercial speech.
Expert Analysis
-
The Next Pressure Point In Digital Health: Informed Consent
Two new federal digital health initiatives will usher in a new era where virtual care, software-enabled devices and home-based monitoring are integrated into care and reimbursement models, with the impact of shifting rules and opportunities felt most immediately in the context of informed consent, says Kimberly Chew at Husch Blackwell.
-
Series
Law School's Missed Lessons: Intentional Career-Building
A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.
-
4 Trends Shaping Drug And Medical Device Law For 2026
2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intelligence, say attorneys at Faegre Drinker.
-
Key Trends In Healthcare Antitrust In 2025
The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.
-
The 5 Most Important Bid Protest Decisions Of 2025
In a shifting bid protest landscape, five decisions in 2025 from the Federal Circuit, the U.S. Court of Federal Claims and the U.S. Government Accountability Office that addressed bedrock questions about jurisdictional reach and the breadth of agency discretion are likely to have a lasting impact, say attorneys at Bradley Arant.
-
Food Industry Braces For MAHA And Other Challenges In 2026
After the Make America Healthy Again movement kept the U.S. Food and Drug Administration under pressure in 2025, actions in the food safety space are likely to continue this year, including updated Supplemental Nutrition Assistance Program dietary guidelines and processed food definitions, say attorneys at Wiley.
-
Preparing For Congressional Investigations In A Midterm Year
2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.
-
A Meaningful Shift In FDA's Biosimilarity Analysis
The U.S. Food and Drug Administration's potential pivot away from routinely requiring comparative efficacy studies for interchangeable biosimilar applications would not lower regulatory standards, but instead allow applicants to allocate resources toward establishing more probative evidence, says Theodore Thompson at Stinson.
-
Employment Immigration Trends And Challenges For 2026
U.S. companies competing for global talent should brace for a turbulent 2026, with greater compliance burdens, higher costs and the probability of workforce disruptions at every stage of the immigration process, from visa petitions to work authorization renewals, say attorneys at Duane Morris.
-
Top 5 Antitrust Issues For In-House Counsel To Watch In 2026
With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.
-
4 Developments That Defined The 2025 Ethics Landscape
The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.
-
Navigating AI In The Legal Industry
As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.
-
How Fractional GCs Can Manage Risks Of Engagement
As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.
-
Health, Legal Employers Face Unique Online Speech Hurdles
Employers in the legal and healthcare industries must consider distinctive ethical obligations and professional requirements when disciplining employees for social media posts, while anticipating an area of the law in flux as courts seek to balance speech rights and the workplace function, say attorneys at FordHarrison.
-
Reviewing 2025's Most Pertinent Wiretap Developments
2025 was a remarkable year in the world of web tracking wiretapping litigation, not only for the increased caseload but also because of numerous developing theories of liability, with disputes expected to continue unabated in 2026, say attorneys at Squire Patton.